Severe myalgia associated with adalimumab treatment in a patient with Crohn's disease

• Published in: The Annals of pharmacotherapy Vol. 42; no. 7; p. 1130
• Main Authors: Hinojosa, Joaquín, Borrás-Blasco, Joaquín, Maroto, Nuria, Rosique-Robles, J Dolores, Alos, Rafael, Casterá, Md Elvira
• Format: Journal Article
• Language: English
• Published: United States 01.07.2008
• Subjects: Adalimumab; Adult; Anti-Inflammatory Agents - adverse effects; Anti-Inflammatory Agents - therapeutic use; Antibodies, Monoclonal - adverse effects; Antibodies, Monoclonal - therapeutic use; Antibodies, Monoclonal, Humanized; Crohn Disease - drug therapy; Female; Humans; Muscular Diseases - chemically induced; Pain - chemically induced

To report a case of severe myalgia associated with adalimumab in a patient with Crohn's disease. A 44-year-old woman was diagnosed as having ileocecal Crohn's disease with perianal fistula lesions. She was treated with 3 infusions of infliximab 5 mg/kg, which stabilized her condition. Howe...